RENO, NV, April 27, 2017 /PRNewswire/ - Earth Life Sciences Inc. (OTCQB:CLTS) ("Earth Life Sciences" or the "Company") ispleased to announce that the Company is working diligently with completing its audited financials for 2016 and first quarter 2017. The financials should be completed within the next two weeks and the company would like to thank its shareholders for their
The company is also happy to announce that significant progress, has been made after developing its business plan which focuses on the CBD side of the Medical Marijuana business and focusing on balancing traditional agricultural practices with cutting edge processes, technologies and unparalleled quality assurance. The acquisition of farmland in the world-famous Okanagan valley of British Columbia Canada gives the company a quality based organic farming focus.
The company has been working diligently to complete the plans to make Okanagan Valley its home base. To develop a Federally compliant nursery and multiple grow room operation for Medical Marijuana. The new Canadian laws, allow for this type of grow facility and the company has been gearing up to get the operation going this year for a first harvest in summer of 2017.
As mentioned in our previous press release, some of the updates have already begun with the company's vision in mind. Now with those initial steps started and with the ongoing efforts by the company, the company can move forward with attaining one of our main goals which is to improve the quality of life for humans as well as their pets. This new division of Earth Life Sciences Inc. will focus on building the Corporate Brand and making the new company a commercial success.
These statements are not guarantees of future performance and involve certain risks and uncertainties that are difficult to predict. Actual results could vary materially from the description contained herein due to many risk factors that affect the industry the Company operates in and other risk factors listed from time to time in the Company's Securities and Exchange Commission (SEC) filings under "risk factors" and elsewhere. The forward-looking statements contained in this press release speak only as of the date on which they are made, and the Company does not undertake any obligation to update any forward-looking statement to reflect events or circumstances after the date of this press release.
SOURCE Earth Life Sciences Inc.
Subscribe to our Free Newsletters!
Yellow fever is a hemorrhagic fever that is transmitted by infected mosquitoes and it can lead to ...
Routes of drug administration play a major role in a medical treatment. Selecting a right route of ...
Spinal anesthesia and epidural anesthesia are types of regional anesthesia in which when a drug is ...View All